Current Issue

Launching a Biological Drug in China: From Biosimilar to Innovative Molecules Key Consider...

Joe X Zhou, Ph.D., CEO Genor BioPharma Jinhai Shi, Ph.D., General Secretary China Protei...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Principal Scientist Janssen R&D

Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Co...

Thorsten Lorenz, PhD, Head Developability Assessment Thomas Jostock, PhD, Science and Te...

Raw Material Qualification – A Practical Approach

Aurora Henry, Biopharmaceutical Professional CMC Biologics

Keys to Successful Implementation of Single-Use Technology

How and why collaboration improves single-use products Willem Kools, PhD., Head of Technol...

How To Select The Right Filter Integrity Test Instrument

Pall Biotech

Headline News

Suven Life Sciences secures Product Patents in India, Singapore, South Korea and Israel

NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA

Glenmark Pharmaceuticals Announces Exclusive Licensing Agreement with Seqirus for its Investigational Seasonal Allergic Rhinitis Nasal Spray – Ryaltris

Read All Headlines

Upcoming Webinars

Challenges in the Development of Continuous Processes for Vaccines

Presented by Danny Vellom of Sanofi Pasteur Biologics, Inc.
04th March 2019

Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics, Novartis
27th September 2018

Lifecycle management of single use technologies

Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
05th March 2019

View All Upcoming Webinars

Past Webinars

Mass Spectrometry – an Essential Tool for Characterization of Monoclonal Antibodies during Development

Presented by Dr Wei Xu & Dr Henry Shion
03rd February 2016

Patient-Centric Drug Delivery Strategies For Oral Paediatric Products

Presented by Dr. Carsten Timpe and Dr. Paolo Gatti
22nd April 2015

Development and Manufacturing of Recombinant Nanoparticle Vaccines

Presented by Atin Tomar, President & CEO, CPL Biologicals Pvt. & Amélie Boulais, Vaccine Platform Marketing Manager, Sartorius Stedim Biotech
12th July 2018

View All Past Webinars

Featured Companies


View All Companies

© 2018 All rights reserved. Privacy Policy